Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 2598 | 2 | LEVOSIMENDAN//CALCIUM SENSITIZER//MILRINONE | 3876 |
| 35398 | 1 | FLOSEQUINAN//BTS 53 554//DIPARTIMENTO SCI FARMACOBIOL COMPLESSO NINI BARBI | 112 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | FLOSEQUINAN | authKW | 5065228 | 21% | 75% | 24 |
| 2 | BTS 53 554 | authKW | 844207 | 3% | 100% | 3 |
| 3 | DIPARTIMENTO SCI FARMACOBIOL COMPLESSO NINI BARBI | address | 633154 | 3% | 75% | 3 |
| 4 | DIALKYLAMINOALKYLNAPHTHALENES | authKW | 562804 | 2% | 100% | 2 |
| 5 | OPIOID LIKE ANALGESICS | authKW | 375202 | 2% | 67% | 2 |
| 6 | 1 2 DIMETHYL 3 PYRROLIDONE | authKW | 281402 | 1% | 100% | 1 |
| 7 | 3 METHYLSULPHONYLAMINO 1 METHYL 41H | authKW | 281402 | 1% | 100% | 1 |
| 8 | 5 ACETYL 2 METHYL 4 METHYLSULFINYL 6 PHENYL 3 2H PYRIDAZINONE | authKW | 281402 | 1% | 100% | 1 |
| 9 | AMINONAPHTHALENIC DERIVATIVES | authKW | 281402 | 1% | 100% | 1 |
| 10 | ARYLPYRROLIDINOLS | authKW | 281402 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 1062 | 38% | 0% | 43 |
| 2 | Pharmacology & Pharmacy | 893 | 52% | 0% | 58 |
| 3 | Chemistry, Medicinal | 211 | 13% | 0% | 15 |
| 4 | Chemistry, Organic | 69 | 13% | 0% | 14 |
| 5 | Chemistry, Analytical | 14 | 6% | 0% | 7 |
| 6 | Critical Care Medicine | 6 | 2% | 0% | 2 |
| 7 | Chemistry, Inorganic & Nuclear | 6 | 4% | 0% | 4 |
| 8 | Peripheral Vascular Diseases | 5 | 3% | 0% | 3 |
| 9 | Medicine, General & Internal | 2 | 4% | 0% | 4 |
| 10 | Behavioral Sciences | 0 | 1% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | DIPARTIMENTO SCI FARMACOBIOL COMPLESSO NINI BARBI | 633154 | 3% | 75% | 3 |
| 2 | DIPARITMENTO CHIM FARMACEUT | 281402 | 1% | 100% | 1 |
| 3 | DIPARTIMENTO FARMACOL SPERIMENTAL PLICATA | 281402 | 1% | 100% | 1 |
| 4 | DIPARTIMENTO FARMACOL SPERIMENTALE PLIC | 281402 | 1% | 100% | 1 |
| 5 | NUCLE PESQUISAS PROD NAT | 281402 | 1% | 100% | 1 |
| 6 | DIPARTIMENTO FARMACOL SPERIMENTALE PL | 225119 | 2% | 40% | 2 |
| 7 | DIPARTIMENTO FARMACOL SPERIMENTALE PLICATA | 214395 | 4% | 19% | 4 |
| 8 | DIPARTIMENTO CHIM FARMACEUT | 162641 | 9% | 6% | 10 |
| 9 | TOKUSHIMA NEW DRUGS 2 | 140700 | 1% | 50% | 1 |
| 10 | GRANDI STRUMENTI | 111171 | 8% | 4% | 9 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2513 | 7% | 0% | 8 |
| 2 | CARDIOVASCULAR DRUGS AND THERAPY | 2285 | 4% | 0% | 4 |
| 3 | CHIRALITY | 2271 | 4% | 0% | 5 |
| 4 | AMERICAN HEART JOURNAL | 1945 | 9% | 0% | 10 |
| 5 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1242 | 6% | 0% | 7 |
| 6 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 849 | 4% | 0% | 5 |
| 7 | JACC-HEART FAILURE | 821 | 1% | 0% | 1 |
| 8 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 635 | 1% | 0% | 1 |
| 9 | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 513 | 2% | 0% | 2 |
| 10 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 437 | 4% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |